Name:
SDS Page Solution Kit
Synonym:
SDS Page Kit; 6% GenAR
CAS:
77-86-1
Section 1 - Chemical Product
MSDS Name:SDS Page Solution Kit
Synonym:SDS Page Kit; 6% GenAR
Synonym:SDS Page Kit; 6% GenAR
Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
| CAS# | Chemical Name | emsds | EINECS# |
| 77-86-1 | Tris (hydroxymethyl) aminomethane | 1.5 | 201-064-4 |
| Hazard Symbols: T Risk Phrases: 20/21/22 45 63 |
Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Harmful by inhalation, in contact with skin and if swallowed. May cause cancer. Possible risk of harm to the unborn child.Cancer suspect agent.Hygroscopic (absorbs moisture from the air).
Potential Health Effects
Eye:
Causes eye irritation. Causes redness and pain. May cause chemical conjunctivitis.
Skin:
Causes skin irritation. Harmful if absorbed through the skin.
Ingestion:
Harmful if swallowed. May cause gastrointestinal irritation with nausea, vomiting and diarrhea.
Inhalation:
Harmful if inhaled. Causes respiratory tract irritation. Central nervous system effects may include confusion, ataxia (failure of muscular coordination), vertigo, tinnitus, weakness, disorientation, lethargy, drowsiness, and finally coma. Can produce delayed pulmonary edema. Inhalation may lead to dizziness, weakness, and drowsiness, leading to stupor, unconsciousness, and even death.
Chronic:
Effects may be delayed. Cancer suspect agent.
Harmful by inhalation, in contact with skin and if swallowed. May cause cancer. Possible risk of harm to the unborn child.Cancer suspect agent.Hygroscopic (absorbs moisture from the air).
Potential Health Effects
Eye:
Causes eye irritation. Causes redness and pain. May cause chemical conjunctivitis.
Skin:
Causes skin irritation. Harmful if absorbed through the skin.
Ingestion:
Harmful if swallowed. May cause gastrointestinal irritation with nausea, vomiting and diarrhea.
Inhalation:
Harmful if inhaled. Causes respiratory tract irritation. Central nervous system effects may include confusion, ataxia (failure of muscular coordination), vertigo, tinnitus, weakness, disorientation, lethargy, drowsiness, and finally coma. Can produce delayed pulmonary edema. Inhalation may lead to dizziness, weakness, and drowsiness, leading to stupor, unconsciousness, and even death.
Chronic:
Effects may be delayed. Cancer suspect agent.
Section 4 - FIRST AID MEASURES
Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid immediately.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid immediately. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid immediately. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.
Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or appropriate foam.
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or appropriate foam.
Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Avoid runoff into storm sewers and ditches which lead to waterways.
Clean up spills immediately, observing precautions in the Protective Equipment section. Absorb spill using an absorbent, non-combustible material such as earth, sand, or vermiculite. Do not use combustible materials such as sawdust. Isolate area and deny entry. Provide ventilation.
Spills/Leaks:
Avoid runoff into storm sewers and ditches which lead to waterways.
Clean up spills immediately, observing precautions in the Protective Equipment section. Absorb spill using an absorbent, non-combustible material such as earth, sand, or vermiculite. Do not use combustible materials such as sawdust. Isolate area and deny entry. Provide ventilation.
Section 7 - HANDLING and STORAGE
Handling:
Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation. Use with adequate ventilation. Wash clothing before reuse.
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances. Keep containers tightly closed. Store protected from moisture.
Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation. Use with adequate ventilation. Wash clothing before reuse.
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances. Keep containers tightly closed. Store protected from moisture.
Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate general or local exhaust ventilation to keep airborne concentrations below the permissible exposure limits.
Exposure Limits CAS# 77-86-1: CAS# 79-06-1: United Kingdom, WEL - TWA: 0.3 mg/m3 TWA United Kingdom, WEL - STEL: 0.9 mg/m3 STEL United States OSHA: 0.3 mg/m3 TWA Belgium - TWA: 0.03 mg/m3 VLE France - VME: 0.1 ppm VME; 0.3 mg/m3 VME Germany: 0.06 mg/m3 TWA (solid); 0.03 mg/m3 TWA Germany: Skin absorber Japan: 0.1 mg/m3 OEL Malaysia: 0.03 mg/m3 TWA Russia: 0.2 mg/m3 TWA Spain: 0.03 mg/m3 VLA-ED CAS# 110-26-9: CAS# 7732-18-5: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHAs eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
A respiratory protection program that meets OSHAs 29 CFR 1910.134 and ANSI Z88.2 requirements or European Standard EN 149 must be followed whenever workplace conditions warrant respirator use.
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate general or local exhaust ventilation to keep airborne concentrations below the permissible exposure limits.
Exposure Limits CAS# 77-86-1: CAS# 79-06-1: United Kingdom, WEL - TWA: 0.3 mg/m3 TWA United Kingdom, WEL - STEL: 0.9 mg/m3 STEL United States OSHA: 0.3 mg/m3 TWA Belgium - TWA: 0.03 mg/m3 VLE France - VME: 0.1 ppm VME; 0.3 mg/m3 VME Germany: 0.06 mg/m3 TWA (solid); 0.03 mg/m3 TWA Germany: Skin absorber Japan: 0.1 mg/m3 OEL Malaysia: 0.03 mg/m3 TWA Russia: 0.2 mg/m3 TWA Spain: 0.03 mg/m3 VLA-ED CAS# 110-26-9: CAS# 7732-18-5: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHAs eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
A respiratory protection program that meets OSHAs 29 CFR 1910.134 and ANSI Z88.2 requirements or European Standard EN 149 must be followed whenever workplace conditions warrant respirator use.
Section 9 - PHYSICAL AND CHEMICAL PROPERTIES
Physical State: Clear liquid
Color: colorless
Odor: odorless
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: 464 deg F ( 240.00 deg C)
Flash Point: 280 deg F ( 137.78 deg C)
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: Soluble.
Specific Gravity/Density:
Molecular Formula:
Molecular Weight:
Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable at room temperature in closed containers under normal storage and handling conditions. Polymerization may occur upon heating.
Conditions to Avoid:
Incompatible materials, excess heat, exposure to moist air or water.
Incompatibilities with Other Materials:
Moisture, acids, alkalies, oxidizing agents, bases.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, carbon dioxide, ammonia.
Hazardous Polymerization: May occur.
Stable at room temperature in closed containers under normal storage and handling conditions. Polymerization may occur upon heating.
Conditions to Avoid:
Incompatible materials, excess heat, exposure to moist air or water.
Incompatibilities with Other Materials:
Moisture, acids, alkalies, oxidizing agents, bases.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, carbon dioxide, ammonia.
Hazardous Polymerization: May occur.
Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 77-86-1: TY2900000 CAS# 79-06-1: AS3325000 CAS# 110-26-9: AS3678000 CAS# 7732-18-5: ZC0110000 LD50/LC50:
CAS# 77-86-1: Oral, rat: LD50 = 5900 mg/kg.
CAS# 79-06-1: Draize test, rabbit, eye: 100 mg/24H Moderate; Draize test, rabbit, skin: 50 mg/3D Mild; Draize test, rabbit, skin: 500 mg/24H Mild; Oral, mouse: LD50 = 107 mg/kg; Oral, rabbit: LD50 = 150 mg/kg; Oral, rat: LD50 = 124 mg/kg; Skin, rabbit: LD50 = 1680 uL/kg; Skin, rat: LD50 = 400 mg/kg.
CAS# 110-26-9: Oral, mouse: LD50 = 380 mg/kg; Oral, rat: LD50 = 390 mg/kg.
CAS# 7732-18-5: Oral, rat: LD50 = >90 mL/kg.
Carcinogenicity:
Tris (hydroxymethyl) aminomethane - Not listed by ACGIH, IARC, or NTP.
Acrylamide - ACGIH: A3 - Confirmed animal carcinogen with unknown relevance to California: carcinogen, initial date 1/1/90 NTP: Suspect carcinogen IARC: Group 2A carcinogen Methylenediacrylamide - Not listed by ACGIH, IARC, or NTP.
Water - Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
CAS# 77-86-1: TY2900000 CAS# 79-06-1: AS3325000 CAS# 110-26-9: AS3678000 CAS# 7732-18-5: ZC0110000 LD50/LC50:
CAS# 77-86-1: Oral, rat: LD50 = 5900 mg/kg.
CAS# 79-06-1: Draize test, rabbit, eye: 100 mg/24H Moderate; Draize test, rabbit, skin: 50 mg/3D Mild; Draize test, rabbit, skin: 500 mg/24H Mild; Oral, mouse: LD50 = 107 mg/kg; Oral, rabbit: LD50 = 150 mg/kg; Oral, rat: LD50 = 124 mg/kg; Skin, rabbit: LD50 = 1680 uL/kg; Skin, rat: LD50 = 400 mg/kg.
CAS# 110-26-9: Oral, mouse: LD50 = 380 mg/kg; Oral, rat: LD50 = 390 mg/kg.
CAS# 7732-18-5: Oral, rat: LD50 = >90 mL/kg.
Carcinogenicity:
Tris (hydroxymethyl) aminomethane - Not listed by ACGIH, IARC, or NTP.
Acrylamide - ACGIH: A3 - Confirmed animal carcinogen with unknown relevance to California: carcinogen, initial date 1/1/90 NTP: Suspect carcinogen IARC: Group 2A carcinogen Methylenediacrylamide - Not listed by ACGIH, IARC, or NTP.
Water - Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
Section 12 - ECOLOGICAL INFORMATION
Ecotoxicity:
When released into the soil, this material is expected to leach into groundwater and may biodegrade to a moderate extent.
When released into the soil, this material is expected to leach into groundwater and may biodegrade to a moderate extent.
Section 13 - DISPOSAL CONSIDERATIONS
Products which are considered hazardous for supply are classified as Special Waste and the disposal of such chemicals is covered by regulations which may vary according to location. Contact a specialist disposal company or the local waste regulator for advice. Empty containers must be decontaminated before returning for recycling.
Section 14 - TRANSPORT INFORMATION
IATA
No information available.
IMO
No information available.
RID/ADR
No information available.
USA RQ: CAS# 79-06-1: 5000 lb final RQ; 2270 kg final RQ
Section 15 - REGULATORY INFORMATION
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: T
Risk Phrases:
R 45 May cause cancer.
R 20/21/22 Harmful by inhalation, in contact with
skin and if swallowed.
R 63 Possible risk of harm to the unborn child.
Safety Phrases:
S 20 When using do not eat or drink.
S 24/25 Avoid contact with skin and eyes.
S 28B After contact with skin, wash immediately with
plenty of water and soap.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
WGK (Water Danger/Protection)
CAS# 77-86-1: 1
CAS# 79-06-1: 3
CAS# 110-26-9: 2
CAS# 7732-18-5: No information available.
Canada
CAS# 77-86-1 is listed on Canadas DSL List.
CAS# 79-06-1 is listed on Canadas DSL List.
CAS# 110-26-9 is listed on Canadas DSL List.
CAS# 7732-18-5 is listed on Canadas DSL List.
CAS# 77-86-1 is not listed on Canadas Ingredient Disclosure List.
CAS# 79-06-1 is listed on Canadas Ingredient Disclosure List.
CAS# 110-26-9 is not listed on Canadas Ingredient Disclosure List.
CAS# 7732-18-5 is not listed on Canadas Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 77-86-1 is listed on the TSCA inventory.
CAS# 79-06-1 is listed on the TSCA inventory.
CAS# 110-26-9 is listed on the TSCA inventory.
CAS# 7732-18-5 is listed on the TSCA inventory.
